Review
Escherichia fergusonii

https://doi.org/10.1016/j.vetmic.2014.04.016Get rights and content

Highlights

  • Escherichia fergusonii causes illness in humans and animals.

  • E. fergusonii is becoming resistant to available antimicrobial therapy.

  • Virulence factors of E. fergusonii are invariably identical or similar to Escherichia coli.

Abstract

Escherichia fergusonii was introduced in the genus Escherichia almost 65 years later than Escherichia coli after which the genus was named. From then (1985) onwards mainly case reports on E. fergusonii associated with disease in individuals of veterinary or human origin have been reported and only very few more extensive studies became available. This has resulted in very fragmented knowledge on this organism. The aim of this manuscript is to give an overview of what is known on E. fergusonii today and to stimulate more research on this organism so that better insight can be obtained in the role that E. fergusonii plays in human and animal infections.

Introduction

Escherichia coli (Bacterium coli) has become by far the most studied bacterium in microbiological research, since its discovery by Theodor Escherich in 1885, probably due to the many different pathogenic isolates that have been recovered from various sites in humans and animals. Bacterium coli was placed in the genus Escherichia in honor of its discoverer in 1919 (Castellani and Chalmers, 1919). It has taken almost 65 years (a century after the discovery by Escherich) before the existence of other species in the genus Escherichia was reported (Farmer et al., 1985). This was probably due to the phenotypic similarity of the various species within the genus Escherichia and the fact that diagnostic tools to identify them, such as PCR (Gokhale et al., 2014, Simmons et al., 2014), whole genome sequencing (Touchon et al., 2009, Walk et al., 2009, Forgetta et al., 2012) and improved growth media including sorbitol or adonitol plates were not available until relatively recently (Pohl et al., 1984, March and Ratnam, 1986, Crawford-Miksza et al., 2009, Wragg et al., 2009, Foster et al., 2010).There are currently seven recognized species in the genus Escherichia. Besides E. coli the genus comprises the species Escherichia albertii (Huys et al., 2003), Escherichia blattae (Burgess et al., 1973), Escherichia fergusonii (Farmer et al., 1985), Escherichia hermanii (Brenner et al., 1982a) and Escherichia vulneris (Brenner et al., 1982b). Escherichia adecarboxylata has also been proposed as a species in the genus Escherichia, but was later reclassified Leclercia adecarboxylata (Tamura et al., 1986). Within the genus Escherichia, E. fergusonii is the closest relative of E. coli, as shown by DNA hybridization (64% similarity)(Lawrence et al., 1991), which may cause difficulty in the diagnostics of these species depending on the diagnostic method used. For example, the ability of E. fergusonii to acquire large portions of the E. coli genome may interfere with PCR dependent diagnostics (Fegan et al., 2006). The other members of the genus are isolated much less frequently than E. coli but from similar sites in the bodies of humans and animals. A striking feature of E. coli is the estimated number of 10,000 naturally occurring varieties/serotypes (and perhaps much more) that exist. These varieties are in part due to the huge number of subtle antigenic variations on the surface of their cells and the presence of “so called” virulence factors. The phylogeny of the genus Escherichia is a complex-story, within the family Enterobactereaceae Escherichia, Shigella and Salmonella are classified as separate genera, but it is argued by some that they are actually Escherichia species (Lan and Reeves, 2002, Escobar-Paramo et al., 2003, Hyma et al., 2005, Yang et al., 2007). Shigella spp. are clinically rather than phylogenetically defined and can be seen as pathogenetic lineages of E. coli. Salmonella was demonstrated to merit the status of a specific species (Ochman and Groisman, 1994). E. coli and Shigella genomes have 70–100% DNA homology. They are positive for indole production, lysine decarboxylase, ornithine decarboxylase and methyl red. While the four different species of Shigella are recognized as E. coli strains (vide supra), E. fergusonii (and E. albertii) are so different from this group that they merit species status (Walk et al., 2009, Forgetta et al., 2012).

Section snippets

Historical perspective

E. fergusonii, formerly known as enteric Group 10, is an infrequently occurring but emerging (Savini et al., 2008) animal and human pathogen, that was named in honor of the American microbiologist William H. Ferguson (Farmer et al., 1985). At the time of discovery the clinical significance of E. fergusonii was uncertain but since then E. fergusonii has been isolated mainly from cases of wound infection, urinary tract infection, bacteremia, diarrhea, pancreatic carcinoma, endophtalmitis and

Infections in animals

Many of the reports on the isolation of E. fergusonii from both animals and humans are case reports in which this bacterium was found to be the infectious agent. In contrast, very few studies have been conducted with the specific intention of isolating E. fergusonii. Oh et al. (2012) isolated and characterized heat-labile enterotoxin producing E. fergusonii from healthy chickens in South Korea. The authors recovered 43 LT producing E. fergusonii isolates, sixteen of which transferred the gene

Infections in humans

The clinical manifestations of E. fergusonii infections in humans include bacteremia, urinary tract infections and diarrhea. The original species description of E. fergusonii was based on isolates recovered from a wide range of human sources including blood, urine, feces and an abdominal wound (Farmer et al., 1985). Later publications on the isolation of E. fergusonii from urinary tract infections (Savini et al., 2008, Bours et al., 2010, Lagacé-Wiens et al., 2010), from a case of sepsis (

Diagnostics

The lack of a selective medium for the isolation of E. fergusonii from materials such as feces, which has a high background flora has been a major hurdle to its detection. Isolation is performed on MacConkey agar in most studies. Wragg et al. (2009) used sorbitol MacConkey agar. The use of citrate adonitol agar significantly reduces the background flora and enhances recovery of E. fergusonii from animal fecal samples (Foster et al., 2010). The need for biochemical tests like a positive

Therapy and prevention

Treatment of E. fergusonii infections is similar to that of E. coli infections but treatment results are more and more hampered by emerging antibiotic resistant strains (Diarrasouba et al., 2007, Fricke et al., 2009). Multidrug-resistant E. fergusonii strains and ESBL producing isolates have been reported repeatedly (Savini et al., 2008, Bours et al., 2010, Lagacé-Wiens et al., 2010, Forgetta et al., 2012, Rayamajhi et al., 2011). Lai et al. (2011) describe a bacteremia caused by E. fergusonii

Prevalence

As mentioned before, the majority of reports on the occurrence of E. fergusonii are case reports. From these reports it has become clear that E. fergusonii can be found worldwide in diseased humans and animals. Studies in which more than only one or a few E. fergusonii cases have been described are rare. Bours et al. (2010) found E. fergusonii to be the third most frequently occurring isolate in human urinary tract infections in Latin America after E. coli and Serratia spp. E. fergusonii, E.

Conclusions

The exact prevalence of cases where E. fergusonii causes illness is not known. Nor is it known whether the organism occurs as a commensal in humans and animals. A remarkable number of the E. fergusonii isolates obtained are multi-resistant and it is suggested that E. fergusonii is becoming resistant to the available antimicrobial therapy (Savini et al., 2008, Rayamajhi et al., 2011, Forgetta et al., 2012). In those studies where virulence factors or virulence genes in E. fergusonii have been

Future research

E. coli and E. fergusonii are each other closest relatives within the genus Escherichia. This and the fact that some E. fergusonii isolates possess genotypic and phenotypic features found in known pathotypes of E. coli lead to a number of questions: is E. fergusonii in fact another E. coli? (but just a little different). What is the prevalence of E. fergusonii, how much under-reported is it? Is the host-specificity of E. coli and E. fergusonii the same? Do pathotypes like UPEF (Urinary

References (54)

  • M.I. Sriram et al.

    Novel lipopeptide biosurfactant produced by hydrocarbon and heavy metal tolerant bacterium Escherichia fergusonii KLU01 as a potential tool for bioremediation

    Bioresource Technol.

    (2011)
  • A.Th.A. Weiss et al.

    Enteritis and septicemia in a horse associated with infection by Escherichia fergusonii

    J. Equi. Vet. Sci.

    (2011)
  • T.M. Wassenaar et al.

    Bacterial virulence: can we draw the line?

    FEMS Microbiol. Lett.

    (2001)
  • P. Wragg et al.

    Characterization of Escherichia fergusonii isolates from farm animals using an Escherichia coli virulence gene array and tissue culture adherence assays

    Res. Vet. Sci.

    (2009)
  • R.L. Bangert et al.

    A survey of the aerobic bacteria in the feces of captive raptors

    Avian Dis.

    (1988)
  • M. Bain et al.

    Isolation of Escherichia fergusonii in cases clinically suggestive of salmonellosis

    Vet. Rec.

    (1999)
  • D.J. Brenner et al.

    Atypical biogroups of Escherichia coli found in clinical specimens and description of Escherichia hermanii sp. nov.

    J. Clin. Microbiol.

    (1982)
  • D.J. Brenner et al.

    Escherichia vulneris: a new species of Enterobacteriaceae associated with human wounds

    J. Clin. Microbiol.

    (1982)
  • N.R. Burgess et al.

    Aerobic bacteria occurring in the hind-gut of the cockroach, Blatta orientalis

    J. Hyg.

    (1973)
  • A. Castellani et al.

    Manual of Tropical Medicine

    (1919)
  • A. Chaudhury et al.

    Enteropathogenicity and antimicrobial susceptibility of new Escherichia spp.

    J. Diarrhoeal. Dis. Res.

    (1999)
  • L.K. Crawford-Miksza et al.

    Misidentification of a variant biotype of Escherichia coli O157:H7 as Escherichia fergusonii by Vitek 2 compact

    J. Clin. Microbiol.

    (2009)
  • F. Diarrasouba et al.

    Antibiotic resistance and virulence genes in commensal Escherichia coli and Salmonella isolates from commercial broiler chicken farms

    J. Food Prot.

    (2007)
  • P. Escobar-Paramo et al.

    The evolutionary history of Shigella and enteroinvasive Escherichia coli revised

    J. Mol. Evol.

    (2003)
  • J.J. Farmer et al.

    Escherichia fergusonii and Enterobacter taylorae, two new species of Enterobacteriaceae from clinical specimens

    J. Clin. Microbiol.

    (1985)
  • N. Fegan et al.

    Escherichia coli O157 somatic antigen is present in an isolate of E. fergusonii

    Curr. Microbiol.

    (2006)
  • J. Freney et al.

    Isolation of Escherichia fergusonii from a patient with septicemia in France

    Eur. J. Clin. Microbiol. Infect. Dis.

    (1987)
  • Cited by (58)

    • Host age increased conjugal plasmid transfer in gut microbiota of the soil invertebrate Caenorhabditis elegans

      2022, Journal of Hazardous Materials
      Citation Excerpt :

      E. coli MG1655 has 99% similarity to S. flexneri and S. sonnei, and 96% similarity to E. fergusonii and B. contaminans, providing evidence that transconjugation were more likely to occur between phylogenetically close species. Most transconjugants (including E. fergusonii, S. flexneri, S. enterica subsp. enerica, S. Typhimurium, A. insuavis) have pili or flagella (Korhonen et al., 1980; Buchanan et al., 1985; Utsunomiya et al., 1992; Eto et al., 2013; Gaastra et al., 2014; Ridderberg et al., 2015), not only promoting cell adhesion and aiding in gut colonization but also forming a channel for the plasmid passage (Huddleston, 2014). Transconjugants including L. brevis and M. paraoxydans are gram-positive bacteria, which agreed with that the IncP-1 plasmid group can be maintained in almost all gram-negative bacteria and also transfer between gram-negative and gram-positive bacteria and even eukaryotic cells (Norberg et al., 2011; Greene, 2014; Ricaboni et al., 2016).

    View all citing articles on Scopus
    View full text